Commercial Weight Loss Programs in the Management of Obesity: an Update.

Commercial Weight Loss Programs in the Management of Obesity: an Update.
复制标题

DOI:
10.1007/s13679-021-00428-y
复制
发表时间:
2021-06
影响因子:
8.8
通讯作者:
Gudzune KA
Gudzune KA
中科院分区:
医学2区
文献类型:
--
作者:
Laudenslager M;Chaudhry ZW;Rajagopal S;Clynes S;Gudzune KA

文献摘要

参考文献

被引文献

相似文献

全面的生活方式计划是肥胖管理的基石,但临床医生转诊可能会受到计划可用性的限制。商业减肥计划可能是一种替代方案,但临床医生可能不知道它们的有效性和安全性。这篇综述描述了商业计划的证据,特别是12个月的减肥,在肥胖症患者中。有几个项目与循证建议一致(即,低热量饮食,增加体力活动和行为策略)。在指南一致的项目中,国家糖尿病预防项目、WW、Jenny克雷格、Medifast和OPTIFAST已经证明了12个月的减肥有效性和安全性。虽然其他项目显示出希望,但在推荐临床医生转诊之前,还需要更多的证据。临床实践指南支持转介到商业减肥计划,有同行评审的证据,以支持其疗效和安全性。临床医生应该考虑现有的证据,病人的喜好,并考虑到这些程序的体重管理时,费用。
Comprehensive lifestyle programs are cornerstones of obesity management, but clinician referrals may be limited by program availability. Commercial weight-loss programs may be an alternative, but clinicians may be unaware of their efficacy and safety. This review describes the evidence for commercial programs, particularly 12-month weight loss, among individuals with obesity. Several programs are concordant with evidence-based recommendations (i.e., lower-calorie diet, increased physical activity, and behavioral strategies). Among the guideline-concordant programs, National Diabetes Prevention Program, WW, Jenny Craig, Medifast and OPTIFAST have demonstrated 12-month weight-loss efficacy and safety. While other programs show promise, more evidence is needed before clinician referral may be recommended. Clinical practice guidelines support referrals to commercial weight-loss programs that have peer-reviewed evidence to support their efficacy and safety. Clinicians should consider the available evidence, patient preference, and cost when considering referrals to these programs for weight management.
DOI: 10.1056/nejmoa012512
发表时间: 2002-02-07
影响因子: 158.5
作者:
Knowler, WC;Barrett-Connor, E;Nathan, DM
通讯作者: Nathan, DM
DOI: 10.1002/oby.22098
发表时间: 2018-03-01
期刊: OBESITY
影响因子: 6.9
作者:
Gorin, Amy A.;Lenz, Erin M.;Foster, Gary D.
通讯作者: Foster, Gary D.
DOI: 10.1503/cmaj.140887
发表时间: 2015-02-17
影响因子: 14.6
作者:
Brauer, Paula;Gorber, Sarah Connor;Tonelli, Marcello
通讯作者: Tonelli, Marcello
DOI: 10.1002/osp4.312
发表时间: 2019-02-01
影响因子: 2.2
作者:
Arterburn, L. M.;Coleman, C. D.;Cook, C. M.
通讯作者: Cook, C. M.
DOI: 10.1002/oby.21403
发表时间: 2016-03
期刊: Obesity (Silver Spring, Md.)
影响因子: --
作者:
Bloom B;Mehta AK;Clark JM;Gudzune KA
通讯作者: Gudzune KA